Presentation is loading. Please wait.

Presentation is loading. Please wait.

Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle  James R. Stelling, M.D., Emily.

Published byDeddy Makmur Modified over 5 years ago

Similar presentations

Presentation on theme: "Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle  James R. Stelling, M.D., Emily."— Presentation transcript:

1 Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle  James R. Stelling, M.D., Emily T. Chapman, B.S., David Frankfurter, M.D., Doria H. Harris, Ph.D., Selwyn P. Oskowitz, M.D., Richard H. Reindollar, M.D.  Fertility and Sterility  Volume 79, Issue 4, Pages (April 2003) DOI: /S (02)04918-X

2 FIGURE 1 Serum hCG level at time of oocyte retrieval in SC and IM groups. Stelling. Subcutaneous vs. intramuscular hCG.Fertil Steril 2003. Fertility and Sterility  , DOI: ( /S (02)04918-X)

3 FIGURE 2 Follicular fluid hCG level at time of oocyte retrieval in SC and IM groups. Stelling. Subcutaneous vs. intramuscular hCG.Fertil Steril 2003. Fertility and Sterility  , DOI: ( /S (02)04918-X)

Download ppt "Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle  James R. Stelling, M.D., Emily."

Similar presentations

Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,

Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.
Sebiha Ozkan, M. D. , Sangita Jindal, Ph. D. , Keri Greenseid, M. D

Sebiha Ozkan, M. D. , Sangita Jindal, Ph. D. , Keri Greenseid, M. D
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after.

Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after.
Craig A. H Richard, Ph. D. , Carolyn J Kubik, M. D

Craig A. H Richard, Ph. D. , Carolyn J Kubik, M. D
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
Modified natural cycle in in vitro fertilization

Modified natural cycle in in vitro fertilization
Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization–embryo.

Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization–embryo.
Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies  Gillian Homan, Susan Brown, R.N., John Moran,

Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies  Gillian Homan, Susan Brown, R.N., John Moran,
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval  David E. Reichman,

In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval  David E. Reichman,
Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles  Tsung-Hsien.

Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles  Tsung-Hsien.

Similar presentations

Ads by Google